Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305414200 on July 23, 2003

J. Biol. Chem., Vol. 278, Issue 44, 43202-43213, October 31, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/44/43202    most recent
M305414200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zander, K.
Right arrow Articles by Schubert, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zander, K.
Right arrow Articles by Schubert, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression*

Kerstin Zander{ddagger}§, Michael P. Sherman§, Uwe Tessmer{ddagger}§, Karsten Bruns{ddagger}, Victor Wray||, Alexander T. Prechtel{ddagger}, Evelyn Schubert{ddagger}, Peter Henklein**, Jeremy Luban{ddagger}{ddagger}, Jason Neidleman¶, Warner C. Greene¶, and Ulrich Schubert{ddagger}§§¶¶||||

From the {ddagger}Heinrich-Pette-Institute of Experimental Virology and Immunology, University of Hamburg, D-20251 Hamburg, Germany, Gladstone Institute of Virology and Immunology, University of California, San Francisco, California 94103, ||Department of Molecular Structure Research, Gesellschaft für Biotechnologische Forschung, D-38124 Braunschweig, Germany, **Institute of Biochemistry, Humboldt University, D-10115 Berlin, Germany, {ddagger}{ddagger}Departments of Microbiology and Medicine, Columbia University, New York, New York 10018, the §§Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, Maryland 20892, and the ¶¶Institute for Clinical and Molecular Virology, University of Erlangen-Nürnberg, D-91054 Erlangen, Germany

Viral protein R (Vpr) of human immunodeficiency virus, type 1 (HIV-1) is the major virion-associated accessory protein that affects a number of biological functions in the retroviral life cycle, including promotion of the transport of the preintegration complex into the nucleus and the induction of G2 host cell cycle arrest. Our recent investigation of the conformational heterogeneity of the proline residues in the N terminus of Vpr suggested a functional interaction between Vpr and a host peptidylprolyl cis/trans isomerase (PPIase) that might regulate the cis/trans interconversion of the imidic bond within the conserved proline residues of Vpr in vivo. Using surface plasmon resonance spectroscopy, Far Western blot, and pulldown experiments a physical interaction of Vpr with the major host PPIase cyclophilin A (CypA) is now demonstrated. The interaction domain involves the N-terminal region of Vpr including an essential role for proline in position 35. The CypA inhibitor cyclosporin A and non-immunosuppressive PPIase inhibitors such as NIM811 and sanglifehrin A block expression of Vpr without affecting pre- or post-translational events such as transcription, intracellular transport, or virus incorporation of Vpr. Similarly to CypA inhibition, Vpr expression is also reduced in HIV-1 infected CypA–/– knock-out T cells. This study thus shows that in addition to the interaction between CypA and HIV-1 capsid occurring during early steps in virus replication, CypA is also important for the de novo synthesis of Vpr and that in the absence of CypA activity, the Vpr-mediated cell cycle arrest is completely lost in HIV-1-infected T cells.


Received for publication, May 23, 2003

* This work was supported in part by NIAID, National Institutes of Health RO1 Grant AI36199 (to J. L.), by NIDDK, National Institutes of Health RO1 Grant DK59537-01, by Grant Schu11/2-1, by Grant SFB 466-A11, by a Heisenberg grant from the Deutsche Forschungsgemeinschaft, and by Grant IE-S08T06 from the German Human Genome Research Project (to U. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Contributed equally to this work.

|||| To whom correspondence should be addressed: Inst. for Clinical and Molecular Virology, University of Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany. Tel.: 49-9131-85-26182; Fax: 49-9131-85-22101; E-mail: ulrich.schubert{at}viro.med.uni-erlangen.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
J. H. Ringrose, R. E. Jeeninga, B. Berkhout, and D. Speijer
Proteomic Studies Reveal Coordinated Changes in T-Cell Expression Patterns upon Infection with Human Immunodeficiency Virus Type 1
J. Virol., May 1, 2008; 82(9): 4320 - 4330.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Votteler, N. Studtrucker, S. Sorgel, J. Munch, E. Rucker, F. Kirchhoff, B. Schick, P. Henklein, T. Fossen, K. Bruns, et al.
Proline 35 of Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Regulates the Integrity of the N-Terminal Helix and the Incorporation of Vpr into Virus Particles and Supports the Replication of R5-Tropic HIV-1 in Human Lymphoid Tissue Ex Vivo
J. Virol., September 1, 2007; 81(17): 9572 - 9576.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. Ardon, E. S. Zimmerman, J. L. Andersen, J. L. DeHart, J. Blackett, and V. Planelles
Induction of g2 arrest and binding to cyclophilin a are independent phenotypes of human immunodeficiency virus type 1 vpr.
J. Virol., April 1, 2006; 80(8): 3694 - 3700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Varin, A.-Z. Decrion, E. Sabbah, V. Quivy, J. Sire, C. Van Lint, B. P. Roques, B. B. Aggarwal, and G. Herbein
Synthetic Vpr Protein Activates Activator Protein-1, c-Jun N-terminal Kinase, and NF-{kappa}B and Stimulates HIV-1 Transcription in Promonocytic Cells and Primary Macrophages
J. Biol. Chem., December 30, 2005; 280(52): 42557 - 42567.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Cantin, S. Methot, and M. J. Tremblay
Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses
J. Virol., June 1, 2005; 79(11): 6577 - 6587.
[Full Text] [PDF]


Home page
J. Virol.Home page
S. Iordanskiy, Y. Zhao, L. Dubrovsky, T. Iordanskaya, M. Chen, D. Liang, and M. Bukrinsky
Heat Shock Protein 70 Protects Cells from Cell Cycle Arrest and Apoptosis Induced by Human Immunodeficiency Virus Type 1 Viral Protein R
J. Virol., September 15, 2004; 78(18): 9697 - 9704.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
P. Romano, Z. He, and S. Luan
Introducing Immunophilins. From Organ Transplantation to Plant Biology
Plant Physiology, April 1, 2004; 134(4): 1241 - 1243.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement